From Patient Advocacy to Underwriting Strategy: Addressing Dialysis-Driven Risk Together
February 26, 2026
February 26, 2026
End Stage Renal Disease (ESRD) affects a very small number of members but is one of the most disruptive and expensive risks in self-funded health plans. Dialysis-driven claims create long-term volatility for employers, stop-loss carriers, and captives, often with little visibility until costs escalate.
Underwriting Management Experts (UME) and Rejuvenate Healthcare recently explored how transplant-focused clinical advocacy can improve outcomes for patients while bringing greater predictability to underwriting and captive performance. In this 30-minute webinar, Vince Lewis, Chief Sales & Marketing Officer, UME, and Dr. Michael Rees, Chief Executive Officer, Rejuvenate Healthcare, connect human impact with smarter risk strategy.
